<DOC>
	<DOCNO>NCT02665559</DOCNO>
	<brief_summary>Testosterone deficiency classically associate development metabolic syndrome , osteoporosis , erectile disorder / reduce libido , depressive syndrome alteration quality patient life . Chronicity HIV infection lead several disorder fever , chronic stress , weight loss cachexia cause hypogonadotropic hypogonadism . On hand , abnormal secretion cytokine , secondary infection may alter Leydig cell cause hypergonadotropic hypogonadism disrupt steroidogenesis . Cases testicular invasion lymphoma Kaposi 's syndrome also describe . The advent antiretroviral therapy reduce prevalence hypogonadism patient infected HIV currently 20 % . This prevalence remain 20 % , regardless antiretroviral therapy CD4-T cell count . No study knowledge far assess exhaustively clinical feature , biological , therapeutic paraclinical hypotestosteronemiae assess level total serum testosterone , SHBG serum free testosterone , among HIV infect patient European population .</brief_summary>
	<brief_title>Study Prevalence Associated Factors With Hypogonadism HIV + Men</brief_title>
	<detailed_description>Assess prevalence clinical , biological , paraclinical therapeutic factor associate primary secondary hypogonadism HIV treat virologically suppressed patient .</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<criteria>Men age 1850 year inclusion visit Under antiretroviral treatment six month undetectable viral load ( last sample old four month visit run ) Infection HIV1 positive ( confirmation full Western blot measurement plasma HIV RNA prior inclusion ) Lack coinfections HBV , HCV ( last negative serology old 6 month screen visit inclusion ) Consent sign patient investigator day inclusion examination require test ( Article L112211 Code Public Health ) Patient affiliate beneficiary social security system European Community member country ( Article L112111 Code Public Health ) . Infection HIV2 All stag cirrhosis Severe renal impairment ( creatinine clearance 30 ml / min ) Opportunistic infection treatment opportunistic infection history Neoplastic pathology process Taken previous 3 month testosterone anabolic agent , antiandrogens , estrogen , glucocorticoid , analog GnRH , growth hormone human insulinlike growth factor1 ( IGF1 ) Pituitary , adrenal testicular pathology , treat Presence history psychotic disorder / high suicide risk Refusal participate No one safeguard justice Patients participate another research evaluate treatment include exclusion period ongoing inclusion</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>Hypogonadism</keyword>
	<keyword>Metabolic Syndrom</keyword>
	<keyword>Reservoirs</keyword>
	<keyword>Osteodensitometry</keyword>
	<keyword>Erectil dysfonction</keyword>
	<keyword>Depression</keyword>
</DOC>